Patient-specific pluripotent stem cells become even more accessible.
In this issue of Cell Stem Cell, Staerk et al. (2010), Seki et al. (2010), and Loh et al. (2010) each describe the derivation of human iPSCs from peripheral blood. Although seemingly incremental, this advance brings the stem cell field an important step closer to eventual clinical use.
Yamanaka
Shinya
S
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. yamanaka@cira.kyoto-u.ac.jp